Literature DB >> 33575875

Role of TSC1 in physiology and diseases.

Karthik Mallela1, Arun Kumar2.   

Abstract

Since its initial discovery as the gene altered in Tuberous Sclerosis Complex (TSC), an autosomal dominant disorder, the interest in TSC1 (Tuberous Sclerosis Complex 1) has steadily risen. TSC1, an essential component of the pro-survival PI3K/AKT/MTOR signaling pathway, plays an important role in processes like development, cell growth and proliferation, survival, autophagy and cilia development by co-operating with a variety of regulatory molecules. Recent studies have emphasized the tumor suppressive role of TSC1 in several human cancers including liver, lung, bladder, breast, ovarian, and pancreatic cancers. TSC1 perceives inputs from various signaling pathways, including TNF-α/IKK-β, TGF-β-Smad2/3, AKT/Foxo/Bim, Wnt/β-catenin/Notch, and MTOR/Mdm2/p53 axis, thereby regulating cancer cell proliferation, metabolism, migration, invasion, and immune regulation. This review provides a first comprehensive evaluation of TSC1 and illuminates its diverse functions apart from its involvement in TSC genetic disorder. Further, we have summarized the physiological functions of TSC1 in various cellular events and conditions whose dysregulation may lead to several pathological manifestations including cancer.

Entities:  

Keywords:  Cancer; Cell proliferation; Hamartin; Migration; PI3K/AKT/MTOR; TSC; TSC1; miRNAs

Mesh:

Substances:

Year:  2021        PMID: 33575875     DOI: 10.1007/s11010-021-04088-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  134 in total

1.  Aberrant beta-catenin signaling in tuberous sclerosis.

Authors:  Baldwin C Mak; Heidi L Kenerson; Lauri D Aicher; Elizabeth A Barnes; Raymond S Yeung
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

2.  Smooth muscle protein-22-mediated deletion of Tsc1 results in cardiac hypertrophy that is mTORC1-mediated and reversed by rapamycin.

Authors:  Amy J Malhowski; Haider Hira; Sarah Bashiruddin; Rod Warburton; June Goto; Blanton Robert; David J Kwiatkowski; Geraldine A Finlay
Journal:  Hum Mol Genet       Date:  2011-01-06       Impact factor: 6.150

3.  Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34.

Authors:  M van Slegtenhorst; R de Hoogt; C Hermans; M Nellist; B Janssen; S Verhoef; D Lindhout; A van den Ouweland; D Halley; J Young; M Burley; S Jeremiah; K Woodward; J Nahmias; M Fox; R Ekong; J Osborne; J Wolfe; S Povey; R G Snell; J P Cheadle; A C Jones; M Tachataki; D Ravine; J R Sampson; M P Reeve; P Richardson; F Wilmer; C Munro; T L Hawkins; T Sepp; J B Ali; S Ward; A J Green; J R Yates; J Kwiatkowska; E P Henske; M P Short; J H Haines; S Jozwiak; D J Kwiatkowski
Journal:  Science       Date:  1997-08-08       Impact factor: 47.728

4.  Identification of a core promoter and a novel isoform of the human TSC1 gene transcript and structural comparison with mouse homolog.

Authors:  Mahmood Ali; Satish C Girimaji; Arun Kumar
Journal:  Gene       Date:  2003-11-27       Impact factor: 3.688

Review 5.  The TSC1-TSC2 complex: a molecular switchboard controlling cell growth.

Authors:  Jingxiang Huang; Brendan D Manning
Journal:  Biochem J       Date:  2008-06-01       Impact factor: 3.857

Review 6.  The tuberous sclerosis complex proteins--a GRIPP on cognition and neurodevelopment.

Authors:  Petrus J de Vries; Christopher J Howe
Journal:  Trends Mol Med       Date:  2007-07-13       Impact factor: 11.951

7.  TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1.

Authors:  Christian C Dibble; Winfried Elis; Suchithra Menon; Wei Qin; Justin Klekota; John M Asara; Peter M Finan; David J Kwiatkowski; Leon O Murphy; Brendan D Manning
Journal:  Mol Cell       Date:  2012-07-12       Impact factor: 17.970

8.  Identification of regions critical for the integrity of the TSC1-TSC2-TBC1D7 complex.

Authors:  Arthur Jorge Santiago Lima; Marianne Hoogeveen-Westerveld; Akio Nakashima; Anneke Maat-Kievit; Ans van den Ouweland; Dicky Halley; Ushio Kikkawa; Mark Nellist
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

9.  Tsc/mTORC1 signaling in oocytes governs the quiescence and activation of primordial follicles.

Authors:  Deepak Adhikari; Wenjing Zheng; Yan Shen; Nagaraju Gorre; Tuula Hämäläinen; Austin J Cooney; Ilpo Huhtaniemi; Zi-Jian Lan; Kui Liu
Journal:  Hum Mol Genet       Date:  2009-10-20       Impact factor: 6.150

10.  Bladder tumour-derived somatic TSC1 missense mutations cause loss of function via distinct mechanisms.

Authors:  Louis S Pymar; Fiona M Platt; Jon M Askham; Ewan E Morrison; Margaret A Knowles
Journal:  Hum Mol Genet       Date:  2008-04-07       Impact factor: 6.150

View more
  6 in total

1.  The Epigenetic Regulatory Protein CBX2 Promotes mTORC1 Signalling and Inhibits DREAM Complex Activity to Drive Breast Cancer Cell Growth.

Authors:  Lucie J Bilton; Chloe Warren; Rebecca M Humphries; Shannon Kalsi; Ella Waters; Thomas Francis; Wojtek Dobrowinski; Pedro Beltran-Alvarez; Mark A Wade
Journal:  Cancers (Basel)       Date:  2022-07-18       Impact factor: 6.575

Review 2.  Of the many cellular responses activated by TP53, which ones are critical for tumour suppression?

Authors:  Gemma L Kelly; Andreas Strasser; Annabella F Thomas
Journal:  Cell Death Differ       Date:  2022-04-08       Impact factor: 12.067

3.  Study on the Expression Profile of Autophagy-Related Genes in Colon Adenocarcinoma.

Authors:  Mingyu Hou; Jiakang Ma; Jun Ma
Journal:  Comput Math Methods Med       Date:  2022-05-04       Impact factor: 2.809

Review 4.  Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects.

Authors:  Silviu Stanciu; Florentina Ionita-Radu; Constantin Stefani; Daniela Miricescu; Iulia-Ioana Stanescu-Spinu; Maria Greabu; Alexandra Ripszky Totan; Mariana Jinga
Journal:  Int J Mol Sci       Date:  2022-09-04       Impact factor: 6.208

5.  QishenYiqi dripping pill protects against myocardial ischemia/reperfusion injury via suppressing excessive autophagy and NLRP3 inflammasome based on network pharmacology and experimental pharmacology.

Authors:  Meng Li; Yueyao Wang; Zhongwen Qi; Zhuo Yuan; Shichao Lv; Yawei Zheng; Zhipeng Yan; Mingyang Wang; Huanjie Fu; Xinbiao Fan; Nan Ji; Ming Liu; Zhuyuan Fang
Journal:  Front Pharmacol       Date:  2022-09-09       Impact factor: 5.988

Review 6.  Mutations in Hsp90 Cochaperones Result in a Wide Variety of Human Disorders.

Authors:  Jill L Johnson
Journal:  Front Mol Biosci       Date:  2021-12-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.